SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

NCT06124924 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Acute Kidney Injury

Interventions

DRUG: SGLT2 inhibitor

Sponsor

University of Minnesota